European Psychiatry : the Journal of the Association of European Psychiatrists
Overview
European Psychiatry is a renowned journal published by the Association of European Psychiatrists. It serves as a platform for the dissemination of cutting-edge research and advancements in the field of psychiatry. With a focus on European perspectives, the journal covers a wide range of topics including clinical practice, neuroscience, psychopharmacology, and psychotherapy. It provides a valuable resource for psychiatrists, researchers, and mental health professionals seeking to stay updated with the latest developments in European psychiatry.
Details
Details
Abbr.
Eur Psychiatry
Publisher
Cambridge University Press
Start
1991
End
Continuing
Frequency
Eight no. a year
p-ISSN
0924-9338
e-ISSN
1778-3585
Country
United Kingdom
Language
English
Specialty
Psychiatry
Metrics
Metrics
h-index / Ranks: 2583
111
SJR / Ranks: 1292
1901
CiteScore / Ranks: 1874
8.80
JIF / Ranks: 720
7.8
Recent Articles
41.
Destoop M, Mohr P, Butlen F, Keri P, Samochowiec J, De Picker L, et al.
Eur Psychiatry
. 2025 Jan;
68(1):e3.
PMID: 39791347
Background: Recent years show an exponential increased interest ("renaissance") in the use of psychedelics for the treatment of mental disorders and broader. Some of these treatments, such as psilocybin for...
42.
Joore N, van der Horst M, Noorthoorn E, Strous J, Vruwink F, Guloksuz S, et al.
Eur Psychiatry
. 2025 Jan;
68(1):e2.
PMID: 39791337
Background: Temperature increases in the context of climate change affect numerous mental health outcomes. One such relevant outcome is involuntary admissions as these often relate to severe (life)threatening psychiatric conditions....
43.
Pemau A, de la Torre-Luque A, Marin-Martin C, Diaz-Marsa M, Andreo-Jover J, Ayad-Ahmed W, et al.
Eur Psychiatry
. 2025 Jan;
68(1):e4.
PMID: 39791330
Background: One of the most relevant risk factors for suicide is the presence of previous attempts. The symptomatic profile of people who reattempt suicide deserves attention. Network analysis is a...
44.
Verdoux H, Bittner R, Hasan A, Qubad M, Wagner E, Lepetit A, et al.
Eur Psychiatry
. 2025 Jan;
68(1):e17.
PMID: 39788917
The European Clozapine Task Force is a group of psychiatrists and pharmacologists practicing in 18 countries under European Medicines Agency (EMA) regulation, who are deeply concerned about the underuse of...
45.
Notredame C, Notredame C, Saint-Dizier C, Saint-Dizier C, Lamer A, Lamer A, et al.
Eur Psychiatry
. 2025 Jan;
68(1):e14.
PMID: 39781612
On January 9, 2022, Belgian pop singer Stromae performed his new hit "L'enfer" live on French TV. The song addresses his personal struggles with suicidal ideation. To evaluate the impact...
46.
Bernstorff M, Hansen L, Olesen K, Danielsen A, Ostergaard S
Eur Psychiatry
. 2025 Jan;
68(1):e12.
PMID: 39773769
Background: Cardiovascular disease (CVD) is twice as prevalent among individuals with mental illness compared to the general population. Prevention strategies exist but require accurate risk prediction. This study aimed to...
47.
Salazar de Pablo G, Perez-Rodriguez V, de Otazu Olivares J, Camacho-Rubio J, Sharma A, Catalan A, et al.
Eur Psychiatry
. 2025 Jan;
68(1):e16.
PMID: 39773691
Background: Estimating the risk of developing bipolar disorder (BD) in children and adolescents (C&A) with depressive disorders is important to optimize prevention and early intervention efforts. We aimed to quantitatively...
48.
Lopez-Castroman J, Artes-Rodriguez A, Courtet P, Hanon C, Gondek T, Baca-Garcia E, et al.
Eur Psychiatry
. 2024 Dec;
67(1):e90.
PMID: 39726377
No abstract available.
49.
Doncarli A, Demiguel V, LE Ray C, Deneux-Tharaux C, Lebreton E, Apter G, et al.
Eur Psychiatry
. 2024 Dec;
67(1):e89.
PMID: 39726376
Background: Postpartum anxiety (PPA) symptoms have harmful effects on child development and mother-infant interactions. Accordingly, in-depth knowledge of associated risk factors is crucial for prevention policies. This study aimed to...
50.
Rossier A, Hallahan B
Eur Psychiatry
. 2024 Dec;
67(1):e88.
PMID: 39697115
Background: While omega-3 polyunsaturated fatty acids (PUFAs) have shown promise as an adjunctive treatment for schizophrenia and other psychotic disorders, the overall consensus about their efficacy across studies is still...